Erlangen, Germany

Peter Meissner

This inventor holds 1 USPTO granted patent. Top assignee: Laevosan-Gesellschaft Gmbh. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Meissner. Retrieved from https://idiyas.com/inventor/peter-meissner-ab3dggoi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Meissner

Introduction

Peter Meissner is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of blocking the attachment of germs to human cells. His work has the potential to impact medical treatments and improve health outcomes.

Latest Patents

Peter Meissner holds a patent for a pharmaceutical preparation that contains one or several galacturonides as the active substance. This preparation has a degree of polymerization of ≥2 and a degree of esterification of <20%. It is designed to block the attachment of germs to mammalian cells, showcasing his innovative approach to combating infections.

Career Highlights

Meissner is associated with Laevosan-Gesellschaft GmbH, where he continues to develop and refine his inventions. His work in the pharmaceutical industry has positioned him as a key figure in the fight against microbial infections.

Collaborations

Some of his notable coworkers include Josef Peter Guggenbichler and Johann Jurenitsch. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Peter Meissner's innovative work in pharmaceuticals exemplifies the importance of research in improving health outcomes. His patent for blocking germ attachment is a testament to his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…